Skip to content

Use of Guidance Videos to Increase Engagement and Decrease Anxiety in Patients Undergoing Pleural Tap

The Effect of Personalized Custom Training Videos on Patient Engagement in Hospitalized Patients Undergoing Thoracocentesis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04254445
Enrollment
100
Registered
2020-02-05
Start date
2020-02-16
Completion date
2020-06-30
Last updated
2020-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pleural Effusion, Pleural Effusion, Malignant, Pleural Pleurisy Effusion

Keywords

Personalized video training, Thoracocentesis, Pleural tap

Brief summary

Patients planned to undergo a pleural tap will get verbal explanation or watch a personalized guidance video in addition to verbal explanation. Questionnaires will be filled to assess the effect of the video training on understanding, cooperation and anxiety.

Detailed description

100 patients with pleural effusion, planned to undergo a diagnostic or therapeutic pleural tap, will be randomized to watch a personalized custom video training, explaining the procedure, in addition to the verbal explanation given by the medical staff, or to get the standard verbal explanation alone. Questionnaires regarding their understanding of the procedure, their feelings and the level of anxiety will be filled before and after the video/verbal explanation, and after the procedure. the study aims to check whether the video training provides better understanding of the procedure, increases cooperation and engagement and decreases anxiety.

Interventions

OTHERPersonalized training video

Using a few demographic and medical details of the patients, provided by the medical staff, the video generator will create a 2-minute personalized custom video, suitable to the age, gender, language, and medical condition of the patients. No identifying information will be used, to protect patient's privacy.

Sponsors

GistMed Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* patients hospitalized in Internal medicine C and D, Tel-Aviv Sourasky Medical Centers * Patients with pleural effusion, planned to undergo diagnostic or therapeutic pleural tap * Patients who can read and understand the questions * Patients who were interested in participating in the clinical trial and signed an informed consent form

Exclusion criteria

* Minors \< 18 years of age * Pregnant women * Patients who cannot read and understand, at the discretion of the investigator * Patients which their medical condition does not allow them to undergo the study procedure

Design outcomes

Primary

MeasureTime frameDescription
Fulfillment of need for information gap30 minutesImprovement of subjective self-assessment of the patient's need of information on the tap procedure following the explanation received, based on the short form of the Quality from Patient Perspective (QPP) measurement. The improvement in the intervention arm will be compared to the one of the control arm
Assessment of Anxiety30 minutesDelta of subjective self-assessment on his/her anxiety about the procedure, following the explanation received (using visual scale of 1-100, based on the Visual Analog Scale (VAS)). The reduction of anxiety in the intervention arm will be compared to the one of the control arm

Secondary

MeasureTime frameDescription
The need of an active role30 MinutesThe patients will be asked to score whether the explanation allowed them the active role they needed, based on the Picker Patient Experience (PPE-15) Questionnaire. The score in the intervention arm will be compared to the one of the control arm
Confidence and Knowledge to take actions30 minutesThe patient would be asked to score whether the information they received allowed them to understand what they should do next, based on the Patient Activation Measure (PAM) Questionnaire. The score in the intervention arm will be compared to the one of the control arm

Countries

Israel

Contacts

Primary ContactOrit Neudorfer, MD
orit.neudorfer@gmail.com+972-54-8886421
Backup ContactOri Rogovsky, MD
orirog@gmail.com+972-52-4266770

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026